2020: A Record Year for Drug Approvals

2021 ◽  
Vol 36 (4) ◽  
pp. 174-175
Author(s):  
Nancy L. Losben

In 2020 The United States Food and Drug Administration?s (FDA) Center for Drug Evaluation and Research (CDER) approved 53 novel drugs, five more than in 2019, but still an aggressive number when compared with 2015 when only 45 new drugs were released to the market. CDER, the largest department within the FDA, has robustly approved a rising number of generic drugs in the last several years, increasing their accessibility and reducing patient and payor costs.

2019 ◽  
Vol 12 (2) ◽  
pp. 52 ◽  
Author(s):  
Danah Al Shaer ◽  
Othman Al Musaimi ◽  
Fernando Albericio ◽  
Beatriz de la Torre

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.


2000 ◽  
Vol 111 (3) ◽  
pp. 199-202 ◽  
Author(s):  
Kuei-Meng Wu ◽  
Joseph G. DeGeorge ◽  
Aisar Atrakchi ◽  
Estella Barry ◽  
Anita Bigger ◽  
...  

2019 ◽  
Vol 75 (1) ◽  
pp. 8-10 ◽  
Author(s):  
Roger Li ◽  
William B. Tabayoyong ◽  
Charles C. Guo ◽  
Graciela M. Nogueras González ◽  
Neema Navai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document